Request Demo
Last update 23 Jan 2025
Taigen Biopharmaceuticals Co. (Beijing), Ltd.
Subsidiary Company|
2004|
Beijing Shi, China
Last update 23 Jan 2025
Overview
Tags
Respiratory Diseases
Infectious Diseases
Urogenital Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20232723
一项III期、多中心、随机、双盲研究，评价TG-1000对比安慰剂在急性流感病毒感染无并发症的成人和青少年患者中的疗效和安全性
[Translation] A Phase III, multicenter, randomized, double-blind study evaluating the efficacy and safety of TG-1000 versus placebo in adults and adolescents with uncomplicated acute influenza virus infection
CTR20231822
中国成年男性健康受试者单次口服[14C]TG-1000的体内物质平衡研究
[Translation] Study on the balance of substances in the body after a single oral administration of [14C]TG-1000 in healthy adult male subjects in China
CTR20202536
II 期、多中心、随机、双盲、剂量范围研究，评价TG-1000 对比安慰剂在急性流感病毒感染无并发症的成人患者的疗效和安全性
[Translation] Phase II, multicenter, randomized, double-blind, dose-ranging study to evaluate the efficacy and safety of TG-1000 versus placebo in adult patients with uncomplicated acute influenza virus infection
100 Clinical Results associated with Taigen Biopharmaceuticals Co. (Beijing), Ltd.
Login to view more data
Login to view more data
100 Deals associated with Taigen Biopharmaceuticals Co. (Beijing), Ltd.
Login to view more data
100 Translational Medicine associated with Taigen Biopharmaceuticals Co. (Beijing), Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 02 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
2
2
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free